Independent investigator grant study-comparative effects of chronic treatment with olanzapine and risperidone on glucose and lipid metabolism.
Phase of Trial: Phase III
Latest Information Update: 30 Oct 2012
At a glance
- Drugs Olanzapine (Primary) ; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 01 Jul 2010 Results have been published in Schizophrenia Research.
- 01 Nov 2009 Results published in the Journal of Clinical Psychiatry.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History